Aromatase inhibitors and their antitumor effects in model systems

Endocrine-Related Cancer

Volumn 6, Issue 2, 1999, Pages 205-210

  Brodie, A ^a   Lu, Q ^a   Liu, Y ^a   Long, B ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ANTIESTROGEN; AROMATASE; AROMATASE INHIBITOR; CYCLINE; DEXAMETHASONE; DNA; ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; LETROZOLE; TAMOXIFEN; TESTOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; NUDE MOUSE; OVARIECTOMY; POSTMENOPAUSE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AROMATASE; AROMATASE INHIBITORS; BREAST NEOPLASMS; CELL DIVISION; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS; MICE; MICE, INBRED BALB C; MODELS, BIOLOGICAL; NEOPLASMS, HORMONE-DEPENDENT; TAMOXIFEN; TRANSFECTION;

EID: 0032974113     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0060205     Document Type: Article

References (18)

1. Blankenstein MA, van de Ven J, de Jong PC & Thijssen JHH 1998 Intratumoral levels of estrogens in breast cancer. Xth International Congress on Hormonal Steroids, Quebec City, Canada.
2. Brodie A, Lu Q, Liu Y, Long B, Wang J-P & Yue W 1998 Preclinical studies using the intratumoral aromatase model for postmenopausal breast cancer. Oncology 12 29-33.
3. Buzdar A, Jonat W, Howell A, Yin H & Lee D 1997 Significant improved survival with Arimidex (anastrozole) versus megestrol acetate in postmenopausal advanced breast cancer: updated results of two randomized trials. Proceedings of the American Society of Clinical Oncology 16 156a.
4. Early Breast Cancer Trials Collaborative Groups 1992 Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomized trials involving 31,000 recurrence and 24,000 deaths among 75,000 women. Lancet 339 1-15.
5. Jordan VC, Rowsby L, Dix CJ & Prestwich G 1978 Dose-related effects of non-steroidal antiestrogens and estrogens on the measurement of cytoplasmic estrogen receptors in the rat and mouse uterus. Journal of Endocrinology 78 71-78.
6. Killackey M.A, Hakes TB & Pierce VK 1985 Endometrial adenocarcinoma in breast cancer patients receiving antiestrogen. Cancer Treatment Report 69 237-238.
7. van Landegham AAJ, Portman J & Nabauurs M 1985 Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Research 45 2900-2906.
8. Lu Q, Nakmura J, Savinov A, Yue W, Weisz J, Dabbs DJ & Wolz GA 1996 Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology 137 3061-3068.
9. Lu Q, Yue W, Wang J-P, Lui Y, Long B & Brodie A 1998 The effects of aromatase inhibitors and antiestrogens in the nude mouse model. Breast Cancer Research and Treatment 50 63-71.
10. Lu Q, Liu Y, Long BJ, Grigoryev D, Gimbel M & Brodie A 1999 The effect of combining aromatase inhibitors with anti-estrogens on tumor growth in a nude mouse model for breast cancer. Breast Cancer Research and Treatment (In Press).
11. McGuire W L 1980 An update on estrogen and progesterone receptors in prognosis for primary and advanced breast cancer. In Hormones and Cancer vol. 15, pp 337-344. Eds S Iacobelli et al. New York: Raven Press.
12. Marty M, Gershanovich M, Campos B, Romieu G, Lurie H, Bonaventura T, Jeffery M, Buzzi F, Ludwig H, Bodrigi I, Reichardt P, O'Higgins N, Chaudri HA, Friederich P & Biachoff MA 1997 Letrozole, a new potent, selective aromatase inhibitor (AI) superior to aminoglutethimide (AG) in postmenopausal women with advanced breast cancer (ABC) previously treated with antiestrogens. Proceedings of the American Society of Clinical Oncology 16 156a.
13. Szyczak J, Milewicz A, Thijssen JHH, Blankenstein MA & Daroszewski J 1998 Concentration of sex steroids in adipose tissue after menopause. Steroids 63 319-321.
14. Wakeling AE & Bowler J 1987 Steroidal pure antiestrogen. Journal of Endocrinology 112 R7-R10.
15. Wakeling AE, Dukes M & Bowler J 1991 A potent specific pure antiestrogen with clinical potential. Cancer Research 51 3867-3873.
16. Yue W, Zhou D, Chen S & Brodie A 1994 A new nude mouse model for postmenopausal breast cancer using MCF-7 cells transfected with the human aromatase gene. Cancer Research 54 5092-5095.
17. Yue W, Wang J-P, Savinov A & Brodie A 1995 Effect of aromatase inhibitors on growth of mammary tumors in a nude mouse model. Cancer Research 55 3073-3077.
18. Yue W, Wang J-P, Hamilton CJ, Demers LM & Santen RJ 1998 In situ aromatization enhances breast tumor estradiol levels and cellular proliferation. Cancer Research 58 927-932.